Get the Stockscreener App
12.14
0.75%
0.09
After Hours:
12.14
Optimizerx Corp stock is traded at $12.14, with a volume of 238.67K.
It is up +0.75% in the last 24 hours and up +32.24% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$12.05
Open:
$12
24h Volume:
238.67K
Relative Volume:
0.43
Market Cap:
$224.59M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-15.18
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
+4.21%
1M Performance:
+32.24%
6M Performance:
+122.75%
1Y Performance:
+0.33%
1-Day Range:
$11.75
$12.27
1-Week Range:
$11.75
$12.77
52-Week Range:
$3.78
$12.78
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
12.14 | 215.47M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
279.70 | 37.97B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
55.18 | 10.83B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.61 | 8.58B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
52.09 | 9.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.98 | 6.68B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Northern Trust Corp Purchases 6,043 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Corp (OPRX) Shares Gap Down to $12.125 on May 28 - GuruFocus
Sherbrooke Park Advisers LLC Sells 22,429 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
D. E. Shaw & Co. Inc. Purchases 32,062 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx’s SWOT analysis: digital health firm’s stock faces growth hurdles - Investing.com
Tang Capital Management LLC Invests $1.08 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
AWM Investment Company Inc. Has $1.05 Million Stake in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
D. E. Shaw & Co. Inc. Raises Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain? - sharewise
Dimensional Fund Advisors LP Boosts Stake in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates - MSN
OptimizeRx Corp (OPRX) Stock Price Up 4.11% on May 19 - GuruFocus
JMP Securities Increases OptimizeRx (NASDAQ:OPRX) Price Target to $14.00 - MarketBeat
OptimizeRx Corp (OPRX) Shares Up 5.92% on May 16 - GuruFocus
OptimizeRx to Participate in Upcoming Investor Conferences - The Manila Times
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - Defense World
JMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $14.00 - Defense World
Dimensional Fund Advisors LP Raises Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
G2 Investment Partners Management LLC Sells 109,041 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Price Target Raised by B. Riley Amid Strong Q1 Performance | OPRX Stock News - GuruFocus
OptimizeRx First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
OptimizeRx (OPRX) Price Target Boosted to $22 by Roth Capital | - GuruFocus
Barclays PLC Boosts Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Wells Fargo & Company MN Purchases 2,797 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx (OPRX) Stock Target Price Raised by JMP Securities | - GuruFocus
OptimizeRX stock target raised to $14 by JMP Securities - Investing.com Nigeria
OPTIMIZERx earnings beat by $0.20, revenue topped estimates - Investing.com Canada
OPRX Exceeds Revenue Expectations in Q1, Cash Reserves Increase - GuruFocus
OptimizeRx (OPRX) Price Target Raised by Stifel | OPRX Stock New - GuruFocus
OPRX Forecasts FY25 Adjusted EBITDA in Range of $13M-$15M | OPRX Stock News - GuruFocus
B. Riley Adjusts Price Target on OptimizeRx to $18 From $13, Maintains Buy Rating - marketscreener.com
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2025 Earnings Call Transcript - Insider Monkey
OptimizeRx (OPRX) Receives Price Target Boost from Stifel | OPRX Stock News - GuruFocus
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - The Manila Times
Earnings call transcript: OptimizeRx Q1 2025 revenue beats forecast, stock surges - Investing.com Canada
Earnings call transcript: OptimizeRx Q1 2025 revenue beats forecast, stock surges By Investing.com - Investing.com South Africa
OptimizeRx Corp Q1 2025 Earnings: EPS of $(0.12) Beats Estimates, Revenue Surges to $21.9 Million - GuruFocus
OptimizeRx (OPRX) Expected to Announce Earnings on Monday - Defense World
JPMorgan Chase & Co. Purchases 52,169 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):